Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Viavi Solutions Inc. Common Stock (VIAV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B), while Viavi Solutions Inc. Common Stock trades at $45.42 (market cap $10.85B). The key difference: Viavi Solutions Inc. Common Stock is far larger — about 4.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Viavi Solutions Inc. Common Stock is more actively traded (4,281,289 versus 4,179,659). Which is the better fit depends on your goals.
| SLS | VIAV | |
|---|---|---|
Market Cap | $2.27B | $10.85B |
Volume | 4,179,659 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $15.46 | $55.33 |
52-Week Low | $1.39 | $12.27 |
Enterprise Value | $2.14B | $10.89B |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →
